From Nasdaq.: 2024-05-16 14:36:35

Investors have taken a bullish stance on Merck & Co (MRK), as seen through significant options trades. The sentiment among big-money traders is split between 54% bullish and 45% bearish. Trades totaling $194,659 for puts and $297,047 for calls indicate a focus on a price band between $120.0 and $131.0.

Examining the volume and open interest for Merck & Co’s options at strike prices between $120.0 and $131.0 reveals crucial insights into liquidity and interest levels. Recent options trades include bullish puts with an exp. date of 07/19/24 and a trade price of $133.5K, and bullish calls with exp. dates in May and June ranging from $40.6K to $64.0K.

Merck & Co is a pharmaceutical company specializing in various therapeutic areas, including cancer and infections. Its immuno-oncology platform is a major sales contributor, along with a substantial vaccine business. Options trading data, in addition to the company’s market position and performance, is being closely monitored by professional analysts setting an average price target of $139.0.

Two professional analysts have recently weighed in on Merck & Co, with a Buy rating from Truist Securities and an Overweight rating from Cantor Fitzgerald. Price targets range from $135 to $143. Options trading presents higher profit potential but is riskier. Serious traders manage risk by staying informed, using multiple indicators, and monitoring markets closely. Stay updated on Merck & Co’s options trades with Benzinga Pro for real-time alerts.

Read more at NASDAQ.: Check Out What Whales Are Doing With MRK